HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I).

Abstract
Elevated plasma aspartylglucosaminidase activity was found in 21/25 cases of CDG Ia, in single cases of CDG Ib, Ic and If, and in 15/16 cases of CDG Ix. The CDG I patients in whom the activity was not raised were either atypical clinically (CDG Ia) or very young (CDG Ih).
AuthorsM Jackson, P Clayton, S Grunewald, G Keir, K Mills, P Mills, B Winchester, V Worthington, E Young
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 28 Issue 6 Pg. 1197-8 ( 2005) ISSN: 0141-8955 [Print] United States
PMID16435229 (Publication Type: Journal Article)
Chemical References
  • Lipids
  • Oligosaccharides
  • Aspartylglucosylaminase
  • Mannose-6-Phosphate Isomerase
  • Phosphotransferases (Phosphomutases)
  • phosphomannomutase
Topics
  • Aspartylglucosylaminase (blood, genetics, metabolism)
  • Carbohydrate Metabolism, Inborn Errors (blood)
  • Fibroblasts (metabolism)
  • Glycosylation
  • Humans
  • Leukocytes (metabolism)
  • Lipid Metabolism
  • Lipids (chemistry)
  • Mannose-6-Phosphate Isomerase (genetics)
  • Oligosaccharides (metabolism)
  • Phosphotransferases (Phosphomutases) (genetics)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: